Physician profile
Lauren Inman
NPI 1396326054
$1,560.56
in general payments reported to CMS, 2019-2025
21 companies · $62.48 in 2025
The $62.48 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $270 · 2022: $519 · 2023: $552 · 2024: $157 · 2025: $62.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $294.56 | 2021-2024 | Rybelsus, Ozempic, Tresiba |
| Abbvie INC. | $171.20 | 2021-2023 | |
| Medtronic, INC. | $145.72 | 2023-2025 | O-Arm, Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.77 | 2021-2024 | Xifaxan |
| Amgen INC. | $140.59 | 2022-2024 | Repatha, Otezla, Krystexxa |
| Antares Pharma, INC. | $84.84 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Hikma Pharmaceuticals USA | $72.70 | 2021-2022 | |
| Lilly USA, LLC | $67.34 | 2022-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $66.18 | 2021-2025 | Farxiga |
| Exact Sciences Corporation | $59.15 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $53.89 | 2023 | Dexcom G6 Transmitter |
| Corium, LLC | $53.39 | 2022-2023 | Azstarys |
| Eyevance Pharmaceuticals LLC | $48.22 | 2021 | |
| Halozyme INC | $30.74 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $25.76 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $24.79 | 2023 | |
| Genentech USA, INC. | $24.56 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.52 | 2023 | |
| Inari Medical, INC. | $13.51 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gt Medical Technologies, INC | $13.03 | 2022 | |
| Esperion Therapeutics, INC. | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Inman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.